Gates Foundation and PAHO Chart a New Path to Democratize Access to Weight-Loss Drugs
In a move that could reshape the global conversation around obesity and health equity, the Bill & Melinda Gates Foundation and the Pan American Health Organization (PAHO) are laying groundwork to make new-generation weight-loss drugs—like Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro—accessible to lower-income nations. What began as a quiet discussion in global health circles…









